Allergist · LMU Klinikum München · Germany (DE) · Immunology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
1 of 1 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 30 May 2026 | Scientific exchange | In person | Rachel Adeyemi | Aurelin | Long-term safety monitoringAdolescent population+1 | 0 | — | Reviewed | ENG-0238 |
30 May 2026
Long-term safety monitoring, Adolescent population, Phase IIb efficacy
LMU Klinikum München
Radiation oncologist
Thoracic medical oncologist
Thoracic medical oncologist
Academic nephrologist
Community nephrologist
Headache specialist
Dermatologist
Allergist